US Map / Florida
State FL

Clinical Trials in Florida

Florida is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Florida and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 616 actively recruiting studies with Florida sites out of 616 registered in total. The busiest research areas in Florida are Breast Cancer, Ovarian Cancer, Obesity. Leading sponsors running trials in the state include Mayo Clinic, University of Miami, AstraZeneca. By stage, Florida trials break down as Phase 1 (127), Phase 2 (199), Phase 3 (160), Phase 4 (19).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
616
Recruiting Now
616
← Back to US Map
Top Conditions in Florida
Breast Cancer (11)Ovarian Cancer (10)Obesity (10)Prostate Cancer (9)Solid Tumor (9)Multiple Myeloma (8)Overweight (8)Pancreatic Cancer (7)Endometrial Cancer (7)Acute Myeloid Leukemia (7)Malignant Solid Neoplasm (6)Non-small Cell Lung Cancer (6)

Frequently Asked Questions — Clinical Trials in Florida

How many clinical trials are currently recruiting in Florida?
ClinicalMetric currently tracks 616 actively recruiting clinical trials with at least one location in Florida. The total number of registered studies—including active but not currently enrolling trials—is 616. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Florida?
Florida hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Ovarian Cancer, Obesity, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Florida serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Florida?
To join a clinical trial in Florida, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Florida maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Florida

NCT07355218 Phase 3
Recruiting
A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With...
Condition
Systematic Lupus Erythematosus
Enrollment
202 pts
Location
United States, Australia, Belgium
Sponsor
EMD Serono Research & Developm
View Trial →
NCT03793348 N/A
Recruiting
Study to Evaluate the Safety and Efficacy of the Cytrellis Micro-Coring Device f...
Condition
Wrinkle
Enrollment
35 pts
Location
United States
Sponsor
Cytrellis Biosystems, Inc.
View Trial →
NCT07823608 Phase 3
Recruiting
A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in ...
Condition
Apnea
Enrollment
258 pts
Location
United States
Sponsor
Pfizer
View Trial →
NCT06562543 Phase 4
Recruiting
A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populati...
Condition
Colorectal Cancer
Enrollment
78 pts
Location
United States, Puerto Rico
Sponsor
Takeda
View Trial →
NCT04634240 N/A
Recruiting
Staged Complete Revascularization for Coronary Artery Disease vs Medical Managem...
Condition
Aortic Stenosis
Enrollment
4,000 pts
Location
United States, Canada
Sponsor
University of British Columbia
View Trial →
NCT07616128 Phase 2
Recruiting
Study of EVO756 in Adults With Migraine
Condition
Migraine
Enrollment
330 pts
Location
United States, Australia, Canada
Sponsor
Evommune, Inc.
View Trial →
NCT06119685 Phase 1, Phase 2
Recruiting
IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients...
Condition
NHL
Enrollment
128 pts
Location
United States
Sponsor
Indapta Therapeutics, INC.
View Trial →
NCT06706674 Phase 3
Recruiting
Multicenter Study of Lumateperone for the Treatment of Irritability Associated W...
Condition
Irritability Associated With Autism Spectrum Disorder
Enrollment
160 pts
Location
United States
Sponsor
Intra-Cellular Therapies, Inc.
View Trial →
NCT06229210 Phase 3
Recruiting
Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizop...
Condition
Schizophrenia
Enrollment
300 pts
Location
United States, Colombia, Serbia
Sponsor
Intra-Cellular Therapies, Inc.
View Trial →
NCT07510048 N/A
Recruiting
Combatting HIV Or Other STIs Early (CHOOSE)
Condition
HIV
Enrollment
200 pts
Location
United States
Sponsor
Westat
View Trial →
NCT07201558 Phase 1
Recruiting
Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE P...
Condition
Rheumatoid Arthritis
Enrollment
48 pts
Location
United States, Australia, Belgium
Sponsor
AstraZeneca
View Trial →
NCT07614984 Phase 2
Recruiting
A Clinical Trial of MK-7262 and Enlicitide in Participants With High Lipoprotein...
Condition
Lipoprotein(a)
Enrollment
750 pts
Location
United States, Canada, Colombia
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT04975152 Phase 1
Recruiting
Neoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Ca...
Condition
Merkel Cell Carcinoma
Enrollment
36 pts
Location
United States
Sponsor
H. Lee Moffitt Cancer Center a
View Trial →
NCT07594015 Phase 2
Recruiting
Pembrolizumab and Lenvatinib in Mismatch Repair Proficient Recurrent Endometrial...
Condition
Recurrent Endometrial Cancer
Enrollment
46 pts
Location
United States
Sponsor
University of Miami
View Trial →
NCT07207174 N/A
Recruiting
Brief Mindfulness-Oriented Recovery Enhancement vs Brief Cognitive-Behavioral Th...
Condition
Chronic Pain
Enrollment
120 pts
Location
United States
Sponsor
Florida State University
View Trial →
NCT06297525 Phase 1
Recruiting
Study of STP938 (Dencatistat) in Advanced Solid Tumours
Condition
Solid Tumor
Enrollment
70 pts
Location
United States, France, United Kingdom
Sponsor
Step Pharma, SAS
View Trial →
NCT07489885 Phase 2
Recruiting
A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoria...
Condition
Psoriasis
Enrollment
75 pts
Location
United States
Sponsor
InventisBio Co., Ltd
View Trial →
NCT06126276 Phase 2
Recruiting
Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Tar...
Condition
Malignant Female Reproductive System Neoplasm
Enrollment
70 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
View Trial →
NCT04256317 Phase 2, Phase 3
Recruiting
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplas...
Condition
Myelodysplastic Syndromes
Enrollment
316 pts
Location
United States, Canada, Czechia
Sponsor
Taiho Oncology, Inc.
View Trial →
NCT06979362 Phase 2
Recruiting
A Research Study Comparing Different Doses of CDR132L With Placebo on the Struct...
Condition
Heart Failure
Enrollment
200 pts
Location
United States, Canada, Germany
Sponsor
Novo Nordisk A/S
View Trial →
NCT07214246 N/A
Recruiting
Follicular Fluid microRNAs in Ovarian Aging and Reproduction
Condition
Ovarian Aging
Enrollment
100 pts
Location
United States
Sponsor
University of Central Florida
View Trial →
NCT06721013 Phase 1, Phase 2
Recruiting
A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia
Condition
Immune Thrombocytopenia (ITP)
Enrollment
68 pts
Location
United States, China, Denmark
Sponsor
Eli Lilly and Company
View Trial →
NCT06996782 Phase 1, Phase 2
Recruiting
A Platform Study in Non-Small Cell Lung Cancer (NSCLC)
Condition
Advanced or Metastatic Non-small Cell Lung Cancer
Enrollment
152 pts
Location
United States, Belgium, Brazil
Sponsor
AstraZeneca
View Trial →
NCT04613596 Phase 2, Phase 3
Recruiting
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and...
Condition
Advanced Non-Small Cell Lung Cancer
Enrollment
626 pts
Location
United States, Argentina, Australia
Sponsor
Mirati Therapeutics Inc.
View Trial →
NCT06672146 Phase 2
Recruiting
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia ...
Condition
Acute Myeloid Leukemia
Enrollment
93 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
View Trial →
Page 10 of 25 — 616 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology